{"id":26542,"date":"2020-06-29T11:53:03","date_gmt":"2020-06-29T09:53:03","guid":{"rendered":"https:\/\/eurogip.fr\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/"},"modified":"2020-09-29T15:18:21","modified_gmt":"2020-09-29T13:18:21","slug":"directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent","status":"publish","type":"post","link":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/","title":{"rendered":"Directive on biological agents: SARS-CoV-2 remains as a risk group 3 agent"},"content":{"rendered":"<p>Parliament and the Commission agreed on 11 June to classify SARS-CoV-2 in risk group 3 of biological agents, adding safeguards to protect workers.<\/p>\n<p>Several groups in the Employment and Social Affairs Committee had tabled an objection to this classification. They argued for a classification in Group 4 to ensure the highest possible levels of health and safety protection for workers.<\/p>\n<p>According to Nicolas Schmit (Employment and Social Rights), the Commission will strongly encourage Member States to ensure that workers exposed to Covid-19 all have written instructions. At the same time, it will assess the need to amend the directive in the light of the lessons learned from the pandemic.<\/p>\n<p>On the basis of these additional guarantees for the health and safety of workers, the resolution opposing the Commission&#8217;s decision was rejected by 35 votes against, 5 in favour and 15 abstentions.<\/p>\n<p>The Commission&#8217;s decision to classify SARS-CoV-2 in risk group 3 of biological agents is therefore adopted and in force. Member States must implement Directive (EU) 2020\/739 by 24 November 2020 at the latest.<\/p>\n<p><a href=\"https:\/\/www.europarl.europa.eu\/news\/en\/press-room\/20200609IPR80804\/employment-meps-reach-consensus-with-commission-on-workers-health-and-safety\">To find out more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Parliament and the Commission agreed on 11 June to classify SARS-CoV-2 in risk group 3 of biological agents, adding safeguards to protect workers. Several groups in the Employment and Social Affairs Committee had tabled an objection to this classification. They argued for a classification in Group 4 to ensure the highest possible levels of health&#8230;<\/p>\n","protected":false},"author":4,"featured_media":26374,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[907],"class_list":["post-26542","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-community-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Directive on biological agents: SARS-CoV-2 remains as a risk group 3 agent - Eurogip<\/title>\n<meta name=\"description\" content=\"responsible for Covid-19, will be classified as a risk group 3 biological agent with additional safeguards to protect the health and safety of workers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Directive on biological agents: SARS-CoV-2 remains as a risk group 3 agent - Eurogip\" \/>\n<meta property=\"og:description\" content=\"responsible for Covid-19, will be classified as a risk group 3 biological agent with additional safeguards to protect the health and safety of workers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/\" \/>\n<meta property=\"og:site_name\" content=\"Eurogip\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-29T09:53:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-29T13:18:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eurogip.fr\/wp-content\/uploads\/2020\/06\/european-parliament-1274765_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1132\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Isabelle Leleu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Isabelle Leleu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/\"},\"author\":{\"name\":\"Isabelle Leleu\",\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/#\\\/schema\\\/person\\\/ecf33c1b8323512588da2815912dafbd\"},\"headline\":\"Directive on biological agents: SARS-CoV-2 remains as a risk group 3 agent\",\"datePublished\":\"2020-06-29T09:53:03+00:00\",\"dateModified\":\"2020-09-29T13:18:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/\"},\"wordCount\":179,\"image\":{\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eurogip.fr\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/european-parliament-1274765_1920.jpg\",\"articleSection\":[\"Community news\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/\",\"url\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/\",\"name\":\"Directive on biological agents: SARS-CoV-2 remains as a risk group 3 agent - Eurogip\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eurogip.fr\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/european-parliament-1274765_1920.jpg\",\"datePublished\":\"2020-06-29T09:53:03+00:00\",\"dateModified\":\"2020-09-29T13:18:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/#\\\/schema\\\/person\\\/ecf33c1b8323512588da2815912dafbd\"},\"description\":\"responsible for Covid-19, will be classified as a risk group 3 biological agent with additional safeguards to protect the health and safety of workers.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eurogip.fr\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/european-parliament-1274765_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/eurogip.fr\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/european-parliament-1274765_1920.jpg\",\"width\":1920,\"height\":1132},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Directive on biological agents: SARS-CoV-2 remains as a risk group 3 agent\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/\",\"name\":\"Eurogip\",\"description\":\"Comprendre les risques professionnels en Europe\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eurogip.fr\\\/en\\\/#\\\/schema\\\/person\\\/ecf33c1b8323512588da2815912dafbd\",\"name\":\"Isabelle Leleu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f3cc67d25190b9c8fc03b41a3a08d1a3f65084bac3fb332e444c9f15a811b63e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f3cc67d25190b9c8fc03b41a3a08d1a3f65084bac3fb332e444c9f15a811b63e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f3cc67d25190b9c8fc03b41a3a08d1a3f65084bac3fb332e444c9f15a811b63e?s=96&d=mm&r=g\",\"caption\":\"Isabelle Leleu\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Directive on biological agents: SARS-CoV-2 remains as a risk group 3 agent - Eurogip","description":"responsible for Covid-19, will be classified as a risk group 3 biological agent with additional safeguards to protect the health and safety of workers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/","og_locale":"en_US","og_type":"article","og_title":"Directive on biological agents: SARS-CoV-2 remains as a risk group 3 agent - Eurogip","og_description":"responsible for Covid-19, will be classified as a risk group 3 biological agent with additional safeguards to protect the health and safety of workers.","og_url":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/","og_site_name":"Eurogip","article_published_time":"2020-06-29T09:53:03+00:00","article_modified_time":"2020-09-29T13:18:21+00:00","og_image":[{"width":1920,"height":1132,"url":"https:\/\/eurogip.fr\/wp-content\/uploads\/2020\/06\/european-parliament-1274765_1920.jpg","type":"image\/jpeg"}],"author":"Isabelle Leleu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Isabelle Leleu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/#article","isPartOf":{"@id":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/"},"author":{"name":"Isabelle Leleu","@id":"https:\/\/eurogip.fr\/en\/#\/schema\/person\/ecf33c1b8323512588da2815912dafbd"},"headline":"Directive on biological agents: SARS-CoV-2 remains as a risk group 3 agent","datePublished":"2020-06-29T09:53:03+00:00","dateModified":"2020-09-29T13:18:21+00:00","mainEntityOfPage":{"@id":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/"},"wordCount":179,"image":{"@id":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/#primaryimage"},"thumbnailUrl":"https:\/\/eurogip.fr\/wp-content\/uploads\/2020\/06\/european-parliament-1274765_1920.jpg","articleSection":["Community news"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/","url":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/","name":"Directive on biological agents: SARS-CoV-2 remains as a risk group 3 agent - Eurogip","isPartOf":{"@id":"https:\/\/eurogip.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/#primaryimage"},"image":{"@id":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/#primaryimage"},"thumbnailUrl":"https:\/\/eurogip.fr\/wp-content\/uploads\/2020\/06\/european-parliament-1274765_1920.jpg","datePublished":"2020-06-29T09:53:03+00:00","dateModified":"2020-09-29T13:18:21+00:00","author":{"@id":"https:\/\/eurogip.fr\/en\/#\/schema\/person\/ecf33c1b8323512588da2815912dafbd"},"description":"responsible for Covid-19, will be classified as a risk group 3 biological agent with additional safeguards to protect the health and safety of workers.","breadcrumb":{"@id":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/#primaryimage","url":"https:\/\/eurogip.fr\/wp-content\/uploads\/2020\/06\/european-parliament-1274765_1920.jpg","contentUrl":"https:\/\/eurogip.fr\/wp-content\/uploads\/2020\/06\/european-parliament-1274765_1920.jpg","width":1920,"height":1132},{"@type":"BreadcrumbList","@id":"https:\/\/eurogip.fr\/en\/directive-on-biological-agents-sars-cov-2-remains-as-a-risk-group-3-agent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eurogip.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Directive on biological agents: SARS-CoV-2 remains as a risk group 3 agent"}]},{"@type":"WebSite","@id":"https:\/\/eurogip.fr\/en\/#website","url":"https:\/\/eurogip.fr\/en\/","name":"Eurogip","description":"Comprendre les risques professionnels en Europe","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eurogip.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/eurogip.fr\/en\/#\/schema\/person\/ecf33c1b8323512588da2815912dafbd","name":"Isabelle Leleu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f3cc67d25190b9c8fc03b41a3a08d1a3f65084bac3fb332e444c9f15a811b63e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f3cc67d25190b9c8fc03b41a3a08d1a3f65084bac3fb332e444c9f15a811b63e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f3cc67d25190b9c8fc03b41a3a08d1a3f65084bac3fb332e444c9f15a811b63e?s=96&d=mm&r=g","caption":"Isabelle Leleu"}}]}},"_links":{"self":[{"href":"https:\/\/eurogip.fr\/en\/wp-json\/wp\/v2\/posts\/26542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurogip.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurogip.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurogip.fr\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/eurogip.fr\/en\/wp-json\/wp\/v2\/comments?post=26542"}],"version-history":[{"count":1,"href":"https:\/\/eurogip.fr\/en\/wp-json\/wp\/v2\/posts\/26542\/revisions"}],"predecessor-version":[{"id":27208,"href":"https:\/\/eurogip.fr\/en\/wp-json\/wp\/v2\/posts\/26542\/revisions\/27208"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eurogip.fr\/en\/wp-json\/wp\/v2\/media\/26374"}],"wp:attachment":[{"href":"https:\/\/eurogip.fr\/en\/wp-json\/wp\/v2\/media?parent=26542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurogip.fr\/en\/wp-json\/wp\/v2\/categories?post=26542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}